Morocco continues to deepen its regulated cannabis ecosystem under Law 13‑21 (2021), with two 2026 developments likely to shape the sector: a new protocol for registering cannabis‑derived health products and a scientific study into cannabis use in animal feed.
Health‑product registration: AMMPS and ANRAC agreement
In March 2026, the Moroccan Agency for Medicines and Health Products (AMMPS) and the National Agency for the Regulation of Cannabis Activities (ANRAC) signed an agreement to establish procedures for registering cannabis‑based health products. This protocol clarifies how licensed cultivators and processors can move from cultivation authorisation to market authorization for medical and therapeutic products.
Animal‑feed research: a new industrial use case
Separately, ANRAC has launched a 10‑month scientific study with the Hassan II Institute of Agronomy and Veterinary Medicine to evaluate cannabis‑derived molecules as alternatives to growth‑promoting antibiotics in poultry feed. If results are positive, this could open a new industrial application beyond medical, cosmetic and traditional uses.
What CBD and hemp businesses should watch
Morocco’s dual track—medical product registration plus industrial research—signals a maturing market. For the medical channel, expect more structured product development with emphasis on pharmaceutical standards. For the industrial channel, monitor the animal‑feed study outcomes and any subsequent regulatory guidance from ANRAC and the Ministry of Agriculture.
Related reading
Information only: cannabis, hemp and CBD laws can change. Check the current requirements with the relevant regulator or a qualified local adviser before acting.